COVID-19 and Hypopituitarism

    Stefano Frara, Paola Loli, Agnese Allora … Andrea Giustina
    Studysummary This review discusses hypopituitarism's bidirectional relationship with COVID-19 due to metabolic comorbidities and pituitary risks, but it reports no new clinical results.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on link.springer.com →
    Discuss this study in the Community →

    Research cited in this study 4

    1. COVID-19 and Endocrine and Metabolic Diseases: An Updated Statement from the European Society of Endocrinology Endocrine · 2021
    2. Sex Differences in COVID-19: The Role of Androgens in Disease Severity and Progression Endocrine · 2020
    3. Androgenetic Alopecia Present in the Majority of Patients Hospitalized with COVID-19: The 'Gabrin Sign' Journal of The American Academy of Dermatology · 2020
    4. A Preliminary Observation: Male Pattern Hair Loss Among Hospitalized COVID-19 Patients in Spain – A Potential Clue to the Role of Androgens in COVID-19 Severity Journal of Cosmetic Dermatology · 2020